Back

Obesity and diabetes, two important modifiable prognostic risk factors after myocardial infarction in women

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Complex coronary syndromes: novel risk markers, comorbidities, and clinical outcomes Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Viveca Ritsinger

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Early hospital readmission after coronary artery bypass grafting in men and women: a retrospective cohort study
Miss M. Maiolino De Carvalho (BR)
Abstract
Presentation thumbnail
The novel use of Transcutaneous Electrical Nerve Stimulation (TENS) in patients with persistent angina due to coronary artery spasm; a pilot study
Miss F. Vervaat (Eindhoven, NL)
Abstract
Presentation thumbnail
Impact of prior coronary revascularisation on clinical presentation and one-year outcomes in acute coronary syndrome
Doctor K. Ichihara (Kobe, JP)
Abstract
Presentation thumbnail
Association between yangxinshi and 1-year all-cause mortality in patients with coronary artery disease without prior cardiovascular events
Professor K. Chen (Tianjin, CN)
Abstract

Access the full session

Session thumbnail
Complex coronary syndromes: novel risk markers, comorbidities, and clinical outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Diabetes predicts in-hospital outcomes in men but not in women with acute myocardial infarction
22 May 2023
thumbnail
Congress Presentation
Study of peculiarities of the cardiological status of obesity patients
29 June 2021
thumbnail
Congress Presentation
Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction
29 August 2025
thumbnail
Congress Presentation
Higher burden of classical, novel and socioeconomic risk factors in young women with type 2 diabetes mellitus in a middle eastern population. Results from the ANCORS-YW Study
25 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources